These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6335020)

  • 21. A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis.
    McGill J; Chapman C
    Br J Ophthalmol; 1983 Nov; 67(11):746-50. PubMed ID: 6357273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
    Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
    Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The enigma of herpes stromal disease.
    McGill J
    Br J Ophthalmol; 1987 Feb; 71(2):118-25. PubMed ID: 3548807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coin-shaped corneal endothelial scar in herpes zoster ophthalmicus: a case report.
    Lee SH; Chun YS; Kim KW
    J Med Case Rep; 2022 Mar; 16(1):107. PubMed ID: 35296348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
    De Clercq E
    Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intentional reactivation of latent ocular herpes infection during BVDU therapy.
    Trousdale MD; Robin JB; Willey DE; De Clercq E
    Curr Eye Res; 1987 Dec; 6(12):1471-7. PubMed ID: 2827960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration.
    Power WJ; Benedict-Smith A; Hillery M; Brady K; Collum LM
    Br J Ophthalmol; 1991 Nov; 75(11):649-51. PubMed ID: 1751456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular penetration and efficacy of chloroethyldeoxyuridine against herpetic keratouveitis.
    Maudgal PC; De Clercq E; Bernaerts R; Dieltiens M; Breemersch M; Van Eeckhoutte L
    Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1453-8. PubMed ID: 3759363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
    De Clercq E
    Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-5-(2-bromovinyl)-2'-deoxyuridine vs. interferon in the systemic treatment of infection with herpes simplex virus of athymic nude mice.
    De Clercq E; Zhen-Xi Z; Descamps J; Huygen K
    J Infect Dis; 1981 Jun; 143(6):846-52. PubMed ID: 6166694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
    Maudgal PC; De Clercq E; Huyghe P
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
    Sundmacher R
    Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical treatment of experimental herpes simplex keratouveitis with 2'-O-glycylacyclovir. A water-soluble ester of acyclovir.
    Maudgal PC; De Clercq K; Descamps J; Missotten L
    Arch Ophthalmol; 1984 Jan; 102(1):140-2. PubMed ID: 6703958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presumed bilateral herpes zoster ophthalmicus in an AIDS patient: a case report.
    Yau TH; Butrus SI
    Cornea; 1996 Nov; 15(6):633-4. PubMed ID: 8899277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration: a double blind controlled study.
    Power WJ; Benedict-Smith A; Hillery M; Brady K; Collum LM
    Curr Eye Res; 1991; 10 Suppl():183-7. PubMed ID: 1907535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral antiviral drugs in experimental herpes simplex keratitis.
    Kaufman HE; Varnell ED; Centifanto-Fitzgerald YM; De Clercq E; Kissling GE
    Antimicrob Agents Chemother; 1983 Dec; 24(6):888-91. PubMed ID: 6318664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acyclovir (Zovirax) ophthalmic ointment: a review of clinical tolerance.
    Grant DM
    Curr Eye Res; 1987 Jan; 6(1):231-5. PubMed ID: 3549163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic ocular zoster.
    Zaal MJ; Maudgal PC; Rietveld E; Suir EP
    Curr Eye Res; 1991; 10 Suppl():125-30. PubMed ID: 1864089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.